Medtronic stock: buy or sell?
August 22nd, 2019
Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.
Should I buy Medtronic stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups match with Medtronic stock now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Medtronic stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 15 ratings published for MDT stock in the last 30 days. The general sentiment of these ratings is bullish for MDT stock, with 11 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-21||Wells Fargo & Co||n/a||Outperform|
|2019-8-21||Morgan Stanley||n/a||Equal Weight|
|2019-8-21||BMO Capital Markets||n/a||Outperform|
|2019-8-21||BMO Capital Markets||n/a||Outperform|
|2019-8-16||Royal Bank of Canada||n/a||Outperform|
|2019-8-14||Morgan Stanley||n/a||Equal Weight|
Medtronic stock analysis
After marking all time highs on Tuesday, Medtronic remained constant 0.04% to $107.83.
After topping to all time highs on Tuesday, Medtronic remained steady 0.04% to $107.83. On July, SMA100d and SMA200d crossed up triggering a rise of 11.33%. Since price and SMA200d lines crossed up on May, MDT climbed $19.56 (22.16%). From a daily perspective, MDT is in a short term uptrend after plotting its last bottom ($100.63, on Aug/15) higher than the previous bottom, and its last top ($109.70, on Tuesday) also over the previous top. Now trading in between its last bottom and last top MDT might consolidate in a plain range, waiting to break out over $109.70 or down under $100.63. On Tuesday, MDT hit a new all time high, pushing higher than on Monday tops. Check different trading setups that use ATHs as triggers.
Medtronic ended this week at $107.83 after reaching a new all time high ($109.70) and climbed a cool 4.93%.
MDT shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom early August, MDT climbed unceasignly breaking out to new all time highs. Since SMA20d and SMA40w crossed up late June, MDT price climbed $8.99 per share (9.10%). Since price and SMA40w lines crossed up late May, MDT climbed $20.58 (23.59%).
Medtronic stock price history
Medtronic stock historical price chart
MDT stock reached all-time highs on Tuesday with a price of $109.70.
Medtronic stock price target is $114.10Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We have 15 price predictions for MDT stock published in the last 30 days:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-21||Wells Fargo & Co||Reiterates||$110.00||$120.00||9.1%|
|2019-8-21||UBS Group||Raises Target||$112.00||$122.00||8.9%|
|2019-8-21||Raymond James||Raises Target||$105.00||$118.00||12.4%|
|2019-8-21||Morgan Stanley||Raises Target||$105.00||$111.00||5.7%|
|2019-8-21||BTIG Research||Raises Target||n/a||$120.00||-|
|2019-8-21||BMO Capital Markets||Reiterates||$107.00||$118.00||10.3%|
|2019-8-21||BMO Capital Markets||Raises Target||$107.00||$118.00||10.3%|
|2019-8-16||Royal Bank of Canada||Raises Target||n/a||$110.00||-|
|2019-8-14||Morgan Stanley||Raises Target||$100.00||$105.00||5%|
Financials and fundamental analysis
Earnings date and Earnings per ShareMedtronic presented slightly good results for 2019-Q1 on February. Medtronic appreciated Earnings per Share (EPS) by 4.00%, beating analysts consensus of $1.24. Medtronic posted $1.29.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Medtronic annual sales remained steady a tight 0.01% to $29,953.00 million USD from $29,950.00 marked in 2018. When comparing 2018 vs 2018, aligned with this, profit margin (that is, the net income divided by revenues) stayed stable a 0.01% to 10.36%. To have an updated view of the financial situation of Medtronic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Medtronic TTM sales up to January 2019 were $30,555.00 and earnings were $4,919.00 M USD. If we compare this TTM figures with the last reported annuality, we can review Medtronic business evolution since April 2018: Annual sales up to January, compared to lastest yearly report, grew a slightly good 2.01%. Regarding profit margin, Medtronic soared 5.74% to 10.36%
|2014||$17,010 M||-||$3,070 M18.0%||-|
|2014||$17,010 M||0.00%||$3,070 M18.0%||0.00%|
|2015||$20,260 M||19.11%||$2,680 M13.2%||-12.70%|
|2015||$20,261 M||0.00%||$2,675 M13.2%||-0.19%|
|2016||$28,830 M||42.29%||$3,540 M12.3%||32.34%|
|2016||$28,833 M||0.01%||$3,538 M12.3%||-0.06%|
|2017||$29,710 M||3.04%||$4,030 M13.6%||13.91%|
|2017||$29,710 M||0.00%||$4,028 M13.6%||-0.05%|
|2018||$29,950 M||0.81%||$3,100 M10.4%||-23.04%|
|2018||$29,953 M||0.01%||$3,104 M10.4%||0.13%|
|TTM||$30,555 M||2.01%||$4,919 M16.1%||58.47%|
Quarterly financial resultsMedtronic reported $7,546.00 million in revenues for 2019-Q1, a 0.87% improvement compared to previous quarter. Reported quarter earnings marked $1,269.00 million with a profit margin of 16.82%. Profit margin inched a 1.91% compared to previous quarter when profit margin was 14.90%. When comparing revenues to same quarter last year, Medtronic sales marked a tiny growth and stepped up a 2.40%. Looking back to recent quarterly results, Medtronic posted 2 positive quarters in a row.
|2017-Q2||$7,920 M||-||$1,160 M14.6%||-|
|2017-Q3||$7,390 M||-6.69%||$1,020 M13.8%||-12.07%|
|2017-Q4||$7,050 M||-4.60%||$2,017 M28.6%||97.75%|
|2018-Q1||$7,369 M||4.52%||$-1,389 M-18.8%||-168.86%|
|2018-Q2||$8,144 M||10.52%||$1,460 M17.9%||-205.11%|
|2018-Q3||$7,384 M||-9.33%||$1,075 M14.6%||-26.37%|
|2018-Q4||$7,481 M||1.31%||$1,115 M14.9%||3.72%|
|2019-Q1||$7,546 M||0.87%||$1,269 M16.8%||13.81%|
Medtronic ownershipWhen you are planning to invest in a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medtronic, 0.06% of all outstanding shares are owned by its staff.
Bearish positions for MDT stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$0.0 M||$148.5 B||$44.5 B||$59.3 B||$2.9 B|
|Total shares||0.0 M||1,760.0 M||510.2 M||1,390.0 M||28.3 M|
|Float shares||1,340.0 M||1,750.0 M||509.5 M||1,390.0 M||27.6 M|
|- Institutional holdings (%)||84.2%||76.5%||88.2%||93.4%||97.5%|
|- Insider holdings (%)||0.1%||0.7%||0.1%||0.2%||1.8%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Thursday, August 22nd, 2019|
|Day range||$107.23 - $108.31|
|Average true range||$2.07|
|50d mov avg||$100.51|
|100d mov avg||$94.84|
|200d mov avg||$92.27|
Medtronic performanceTo measure stock performance is always good to benchmark with competitors or related stocks. We chose , Baxter International, Boston Scientific, CONMED, Edwards Lifesciences, Integra LifeSciences, , Owens & Minor, Stryker and Zimmer Biomet as the bechmarking frame for Medtronic stock.
|OMIOwens & Minor||38.51%||-24.33%||-70.27%|
Medtronic competitorsWe selected a few stocks to conform a list of Medtronic competitors to check if you are interested in investing in MDT:
- Baxter International (BAX)
- Boston Scientific (BSX)
- CONMED (CNMD)
- Edwards Lifesciences (EW)
- Integra LifeSciences (IART)
- Owens & Minor (OMI)
- Stryker (SYK)
- Zimmer Biomet (ZBH)
Latest Medtronic stock news
- InvestorPlace3 Big Stock Charts for Monday: Medtronic, Paychex and AbbVieJune 24, 2019
- InvestorPlace3 Big Stock Charts for Friday: Medtronic, LKQ and Lamb WestonMarch 15, 2019
- InvestorPlaceMedtronic Earnings: MDT Reports Q3 Earnings BeatFebruary 19, 2019
- InvestorPlace3 Big Stock Charts for Tuesday: Microsoft, Medtronic and Intercontinental ExchangeJanuary 8, 2019
- InvestorPlace3 Big Stock Charts for Thursday: Medtronic, Facebook and eBayJanuary 3, 2019